Immunobridging data used in Pfizer vaccine study for kids
SHREVEPORT, La. - Pfizer announced Monday that clinical trial data shows its vaccine is safe and effective for children ages 5-11. |!| Shreveport
SHREVEPORT, La. - Pfizer announced Monday that clinical trial data shows its vaccine is safe and effective for children ages 5-11. |!| Shreveport